Citation:
Efentakis P, Varela A, Sanoudou D, Davos C, Klinakis A, Papapetropoulos A, Cokkinos DV, Iliodromitis EK, Wenzel P, Andreadou I. P3488 Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling. European Heart Journal. 2019;40:ehz745–0356.